SMi proudly presents the 5th annual COPD: Novel Therapeutics and Management conference which will expand on last year’s themes to provide cutting edge concepts in COPD from the experts within industry and academia. 

Following on in this successful series, the 2013 agenda has evolved to include topical and current sessions such as, exacerbations, as well as presenting attendees with in-depth information on areas including lung biomarkers, combination therapies, comorbidities, immunology, optimising patient selection in trials, and challenges in COPD drug discovery and development. 

This market-leading event will be led by key opinion leaders and industry experts to provide current advances, issues, and challenges as well as an unrivalled opportunity for debate and discussion.

For further information click here